Joyzyme Group Limited

HK$0.28As of Sun 8 Nov 2026, 12:00 UTC
HKEX:8622Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 8Y CAGR (4.52%)
Div yield —
ROE (10.02%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.83
PE TTM —
TSR TTM (48.18%)
Mkt cap HK$146.9M
ROIC (42.87%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.30
5.20%
(93.70%)
Hold 0|3|9|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
17.94%
13.77%
14.89%
22.04%
Revenue¥M
14.30
14.16
14.01
14.48
2.86%
4.29%
(2.57%)
2.97%
Peers (US$18.74M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.320
(0.055)
(0.046)
EBIT/Intx
5.669
0.198
0.192
Own earn%
258.39
(25.51)
(42.01)
Sh yield%
44.47
50.32
50.88
Owners
Insiders/Inst%
9.62
49.41
Short interest%
4.36
SBC / revenue%
5.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
2–9
$1 testx
—
Incr. ROIC%
−3